Skip to main content

Avadel Pharmaceuticals PLC

AVDLDelisted Feb 12, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001012477

Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Avadel Pharmaceuticals PLC changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of AVDL: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders10199−2
Shares52.0M54.4M+2.42M (+4.7%)
Value$856.2M$559.4M−$296.8M (−34.7%)

New holders (14)

Institutions that held Avadel Pharmaceuticals PLC at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to AVDL in Q3 2023
InstitutionSharesValue% of portfolio
Tang Capital Management LLC1,000,000$10.3M1.45%
Cetera Advisors LLC87,871$905.1K0.01%
Lion Point Capital, LP80,000$824.0K0.75%
Millennium Management LLC54,726$563.7K0.00%
Jump Financial, LLC53,571$551.8K0.02%
Qube Research & Technologies Ltd53,523$551.3K0.00%
Silverback Asset Management LLC100,000$290.0K0.04%
Virtu Financial LLC20,047$206.0K0.02%
Resources Investment Advisors, LLC.19,388$199.7K0.00%
GTS Securities LLC17,164$176.8K0.00%
Squarepoint Ops LLC14,582$150.2K0.00%
Exencial Wealth Advisors, LLC12,000$123.6K0.01%
Quantbot Technologies LP7,587$78.1K0.01%
GWM Advisors LLC1,300$13.4K0.00%

Sold out (16)

Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2023 and filed for Q3 2023 without it.